ESMO Press Office

Latest releases


In view of the spread of Coronavirus infections across Europe and now increasingly in France, ESMO has made the difficult but necessary decision not to proceed with the TAT Congress, due to take place 2-4 March in Paris.

Read more

The ESMO Press Office welcomes media professionals interested in reporting on cancer

For enquiries please contact us on

ESMO on Twitter

Press releases from meetings


Due to the current situation with the Covid-19 infection, it is not possible to proceed with the ESMO Breast Cancer Congress in its original format.

ELCC Congress cancelled

In due consideration of the latest information on the Coronavirus outbreak, ESMO and IASLC have made the unavoidable decision to cancel the ELCC 2020 Congress, due to take place 15-18 April in Geneva, Switzerland.

Pathology/Molecular biology;  Translational research

The QuIP Study Attempts to Harmonise the Use of TMB Panels

TMB is actively being studied as a predictive biomarker for identifying patients who might benefit from immunotherapy but the issue of variability between assays has been raised

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings